Clinical Trials Browser

Interventional × ASTX-660 × 90 days × Clear all

NCT05403450 2026-02-23

A Study of Tolinapant in Combination With Oral Decitabine/Cedazuridine and Oral Decitabine/Cedazuridine Alone in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma (R/R PTCL)

Phase 1 Active not recruiting

Lymphoma, Non-Hodgkin, Lymphoma, T-Cell, Peripheral

NCT05082259 2026-02-10

ASTEROID

Phase 1 Recruiting

BreastGynecologic

Uterine Cervical Neoplasms, Triple Negative Breast Neoplasms

NCT05245682 2026-01-08

Tolinapant and Radiation for Cisplatin-Ineligible, Previously Untreated, Locally Advanced Head and Neck Cancer

Phase EARLY_PHASE1 Active not recruiting

10 enrolled 8 charts

Head & NeckOther solid neoplasm

Head and Neck Carcinoma of Unknown Primary